These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17049192)

  • 61. Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
    Ahmad Z; Fraig MM; Bisson GP; Nuermberger EL; Grosset JH; Karakousis PC
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1527-32. PubMed ID: 21282447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis.
    Vladimirsky MA; Ladigina GA
    Biomed Pharmacother; 1982; 36(8-9):375-7. PubMed ID: 7182018
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liposomes as drug delivery systems for the treatment of TB.
    Pinheiro M; Lúcio M; Lima JL; Reis S
    Nanomedicine (Lond); 2011 Oct; 6(8):1413-28. PubMed ID: 22026379
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator.
    Uchida Y; Casali N; White A; Morici L; Kendall LV; Riley LW
    Cell Microbiol; 2007 May; 9(5):1275-83. PubMed ID: 17223927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.
    López Y; Yero D; Falero-Diaz G; Olivares N; Sarmiento ME; Sifontes S; Solis RL; Barrios JA; Aguilar D; Hernández-Pando R; Acosta A
    Int J Med Microbiol; 2009 Aug; 299(6):447-52. PubMed ID: 19157977
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effectiveness of a liposomal form of rifampicin in the treatment of experimental tuberculosis in mice].
    Kurunov IuN; Kaledin VI; Popova NA; Panteleeva AG
    Probl Tuberk; 1992; (1-2):13-5. PubMed ID: 1603780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
    Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
    Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.
    Sekiguchi J; Nakamura T; Miyoshi-Akiyama T; Kirikae F; Kobayashi I; Augustynowicz-Kopec E; Zwolska Z; Morita K; Suetake T; Yoshida H; Kato S; Mori T; Kirikae T
    J Clin Microbiol; 2007 Sep; 45(9):2802-7. PubMed ID: 17596354
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Determining drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide].
    Nizova AV; Stepanshina VN; Maĭskaia NV; Mironova RI; Bogun AG; Domotenko LV; Morozova TP; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2008; (4):23-6. PubMed ID: 19172875
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis.
    Chen F; Zhou J; Luo F; Mohammed AB; Zhang XL
    Biochem Biophys Res Commun; 2007 Jun; 357(3):743-8. PubMed ID: 17442275
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A; Jaafari MR; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
    Exp Parasitol; 2009 Apr; 121(4):362-9. PubMed ID: 19211022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epigenetic changes in the rat livers induced by pyrazinamide treatment.
    Kovalenko VM; Bagnyukova TV; Sergienko OV; Bondarenko LB; Shayakhmetova GM; Matvienko AV; Pogribny IP
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):293-9. PubMed ID: 17920094
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effectiveness of antibacterial preparations incorporated into liposomes in the treatment of experimental tuberculosis].
    Kurunov IuN; Nikolin VP; Kaledin VI; Matienko NA; Budker VG
    Probl Tuberk; 1982 Oct; (10):54-8. PubMed ID: 7178105
    [No Abstract]   [Full Text] [Related]  

  • 75. Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2006 Jun; 57(6):1146-52. PubMed ID: 16597631
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selection of genes of Mycobacterium tuberculosis upregulated during residence in lungs of infected mice.
    Srivastava V; Jain A; Srivastava BS; Srivastava R
    Tuberculosis (Edinb); 2008 May; 88(3):171-7. PubMed ID: 18054522
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
    Deol P; Khuller GK
    Biochim Biophys Acta; 1997 Mar; 1334(2-3):161-72. PubMed ID: 9101710
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats.
    Domingo M; Gil O; Serrano E; Guirado E; Nofrarias M; Grassa M; Cáceres N; Pérez B; Vilaplana C; Cardona PJ
    Scand J Immunol; 2009 Jun; 69(6):500-7. PubMed ID: 19439010
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.